product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-Bim (Ser69) Antibody
catalog :
4581
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human, mouse, rat, dog
application :
western blot, immunoprecipitation
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot; human; loading ...; fig 5a
Li Y, Buijs Gladdines J, Canté Barrett K, Stubbs A, Vroegindeweij E, Smits W, et al. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study. PLoS Med. 2016;13:e1002200 pubmed publisher
  • western blot; human; fig 6
Luan Q, Jin L, Jiang C, Tay K, Lai F, Liu X, et al. RIPK1 regulates survival of human melanoma cells upon endoplasmic reticulum stress through autophagy. Autophagy. 2015;11:975-94 pubmed publisher
Periyasamy Thandavan S, Takhar S, Singer A, Dohn M, Jackson W, Welborn A, et al. Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim. Breast Cancer Res. 2012;14:R52 pubmed
product information
SKU :
4581S
Product-Name :
Phospho-Bim (Ser69) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, M, (R, Mk, Dg)
Applications :
Immunoprecipitation
Product-Category :
Apoptosis
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
26
Host :
Rabbit
Target :
Bim (Ser69) phosphate
Primary-Protein :
Bim
Alt-Names :
B2L11,BAM,BCL2-like 11 (apoptosis facilitator),BCL2L11,BIM,BIM-alpha6,BIM-beta6,BIM-beta7,BOD,Bcl-2-like protein 11,Bcl2-L-11,Bcl2-interacting mediator of cell death,BimEL,BimL,bcl-2 interacting mediator of cell death,bcl-2 interacting protein Bim,bcl-2-related ovarian death agonist
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.